Clinical Experience in the Management of Cerebral Vasospasm Using Intravenous Isoproterenol and Lidocaine Hydrochloride
We have recently reported our initial clinical experience using a combination of isoproterenol and lidocaine hydrochloride for cerebral vasospasm following subarachnoid hemorrhage (12). Further clinical experience along with preliminary laboratory investigations justifies a progress report. The patients reported here through April 1973 represent 20% of those operated during the period of the report and comprise a group suffering primarily from progressive vasospasm; other causes for deterioration such as communicating hydrocephalus edema, or surgical trauma were considered of secondary importance.
KeywordsCerebral Vasospasm Adrenergic Nerve Lidocaine Hydrochloride Initial Clinical Experience Neurosurgical Intensive Care Unit
Unable to display preview. Download preview PDF.
- 11.Smigiel, M. R., and Sundt, T. M., Jr.: “Laboratory studies in cerebral vasospasm.” (In preparation.)Google Scholar
- 12.Sundt, T. M., Jr., Onofrio, B. M., and Merideth, J.: “Clinical trial with isoproterenol and lidocaine hydrochloride for vasospasm of subarachnoid hemorrhage.” J. Neurosurg. (In press.)Google Scholar
- 13.Symon, L.: “Vasospasm in aneursym.” In: Cerebral Vascular Diseases. I. Moossy and R. Janeway, eds. New York: Grune & Stratton (1971), pp. 232–240.Google Scholar